Podcasts about quintilesims

Paula Brown Stafford and Lisa T. Grimes are two award-winning, c-suite executives who together have accumulated 60 plus years of work experience at the highest levels, 60 years of marriage, and raised four successful children. Collectively, they have managed more than 25,000 employees globally. Paula recently retired as President, Clinical Development at QuintilesIMS and Lisa has served as President & CEO of PurThread Technologies. Although Paula and Lisa were fierce competitors 20 years ago, they eventually formed a friendship and now, as a team, speak to corporations and women’s groups on a number of topics, including Complementing Not Competing, Packing Your Potential, and The Juggling Act. Together, Paula and Lisa wrote the book, Remember Who You Are: Achieve Success. Create Balance. Experience Fulfillment. ----- Finding balance in the midst of a successful career is a challenge – and women face unique challenges as they rise up the ranks in business. Paula Brown Stafford and Lisa Grimes know that first hand, so their stories and advice are truly priceless. In business, you will inevitably face competition – but there is more to advancing and excelling in your career. Mentorship is a huge factor in building on your skills and experience. Learning from someone who went down this path before you can open doors and open your mind to seeing a path more clearly. Paula Brown Stafford and Lisa Grimes are my guests on Absolute Advantage today, and we had a wonderfully animated conversation. From competing for multi-million dollar contracts 20 years ago, to literally finishing each other’s sentences – the respect Lisa and Paula have for each other really shows through. What sticks with me is the way they are giving back – offering guidance not just to women in (or on their way to) positions of power, but men too as we all interact together. Respect is the key that provides a way forward for everyone. The book they co-wrote even includes – cleverly I thought – a “Her Perspective” forward and and “His Perspective” forward. We talked — among many topics — about networking and cultivating your personal brand. These are important elements of building a trifecta of success, balance and fulfillment. Lisa and Paula also worked with this great juggling metaphor: in life you juggle so much. You have crystal balls, glass balls, rubber balls, plastic balls and lead balls – you’ll just have to listen to find out more! What these two share on this subject is really powerful. The c-suite and life experience both Lisa and Paula have had brings unique and powerful insights we can all learn from. So if you like the idea of success, balance and fulfillment, our conversation is a great one to get in on. Thank you for listening today! I appreciate your time so very much. Ways to contact Paula and Lisa: Website: habergeon.com

In this episode Paula Brown Stafford and Lisa T. Grimes offer a Biblical perspective on gender roles in the workplace. Paula Brown Stafford is a clinical researcher, business leader, and lecturer. She is a distinguished alumna at the University of North Carolina at Chapel Hill, where she is also an Adjunct Professor. Previously she was president of clinical development at QuintilesIMS, a Fortune 500 company. Lisa T. Grimes is a business leader, coach and speaker. She has spent most of the last 30 years in healthcare and lifestyle start-ups where she has served as CEO of PurThread Technologies, InSite Clinical Trials, and AcSentient. Together, Paula and Lisa founded Habergeon to help women achieve success, create balance, and experience fulfillment. And they’re also the co-authors of a new book, Remember Who You Are: Achieve Success. Create Balance. Experience Fulfillment. https://habergeon.com/ Christianity in Business is the show that helps Christian business leaders to integrate biblical values into business. | Entrepreneurship | Marketing | Nonprofit | Church | Author | Startups | Marketplace | Ministry | Business as Mission | Faith and Work | Faith | Success | Leadership | www.ChristianityInBusiness.com

Paula Brown Stafford and Lisa T. Grimes are two award-winning, c-suite executives who together have accumulated 60 plus years of work experience at the highest levels, 60 years of marriage, and raised four successful children. Collectively, they have managed more than 25,000 employees globally. Paula recently retired as President, Clinical Development at QuintilesIMS and Lisa has served as President & CEO of PurThread Technologies. Although Paula and Lisa were fierce competitors 20 years ago, they eventually formed a friendship and now, as a team, speak to corporations and women’s groups on a number of topics, including Complementing Not Competing, Packing Your Potential, and The Juggling Act. Paula Brown Stafford is a clinical researcher, business leader, and lecturer. She is a distinguished alumna at the University of North Carolina at Chapel Hill, where she is also an Adjunct Professor. Previously she was president of clinical development at QuintilesIMS, a Fortune 500 company. She lives in Chapel Hill, NC with her husband and has two adult children. Lisa T. Grimes is a business leader, coach and speaker. She has spent most of the last 30 years in healthcare and lifestyle start-ups where she has served as CEO of PurThread Technologies, InSite Clinical Trials and AcSentient. She loves to connect people and often does so through her work with non-profit organizations. She lives in Cary, NC with her husband and has two adult sons. Together, Paula and Lisa founded Habergeon to help women achieve success, create balance, and experience fulfillment. They are dedicated to giving back and are donating a portion of all proceeds from book sales to some of their favorite charities.

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Roche, Iqvia, Novartis, EMA, FDA, Gilead, Boehringer Ingelheim, Dicerna Pharmaceuticals, Abbott.Persone: Ari Bousbib (Iqvia), Rita Banzi (Istituto Mario Negri di Milano), Beatrice Lorenzin (Ministro della Salute).Nuove terapie: vemurafenib, alectinib, CTL019.Patologie: malattia Erdheim-Chester, tumore al polmone, leucemia, NASH, diabete.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Roche, Iqvia, Novartis, EMA, FDA, Gilead, Boehringer Ingelheim, Dicerna Pharmaceuticals, Abbott.Persone: Ari Bousbib (Iqvia), Rita Banzi (Istituto Mario Negri di Milano), Beatrice Lorenzin (Ministro della Salute).Nuove terapie: vemurafenib, alectinib, CTL019.Patologie: malattia Erdheim-Chester, tumore al polmone, leucemia, NASH, diabete.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: AstraZeneca, Aspen, Genenta Science, QuintilesIMS, LabCorp, Covance, PPD, Icon, INC Research, inVentiv Health, PRA Health Sciences, Parexel, BioClinica, Medpace, Premier Research, Teva Pharmaceuticals, Lundbeck, FDA, Amgen, Persone: Pierluigi Paracchi (Genenta Science), Luigi Naldini (Genenta Science) e Bernhard Gentner (Genenta Science), Guido Guidi (Genenta Science), Kenneth C. (Genenta Science), Kare Schultz (Teva Pharmaceuticals), Vytenis Andriukaitis (European Commissioner for Health and Food Safety), Jean-Pierre Bourguignon (European Research Council), Andrea Fontanella (FADOI).Nuove terapie: Mvasi, olaratumab.Patologie: sepsi, Parkinson, cancro, sarcoma.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: AstraZeneca, Aspen, Genenta Science, QuintilesIMS, LabCorp, Covance, PPD, Icon, INC Research, inVentiv Health, PRA Health Sciences, Parexel, BioClinica, Medpace, Premier Research, Teva Pharmaceuticals, Lundbeck, FDA, Amgen, Persone: Pierluigi Paracchi (Genenta Science), Luigi Naldini (Genenta Science) e Bernhard Gentner (Genenta Science), Guido Guidi (Genenta Science), Kenneth C. (Genenta Science), Kare Schultz (Teva Pharmaceuticals), Vytenis Andriukaitis (European Commissioner for Health and Food Safety), Jean-Pierre Bourguignon (European Research Council), Andrea Fontanella (FADOI).Nuove terapie: Mvasi, olaratumab.Patologie: sepsi, Parkinson, cancro, sarcoma.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

This week on DisrupTV, we interviewed Tasha Keeney, Analyst at ARK Invest, Ophir Gottlieb, CEO & Co-Founder at Capital Market Laboratories, and Richie Etwaru, CDO at QuintilesIMS and author of "Blockchain: Trust Companies." DisrupTV is a weekly Web series with hosts R “Ray” Wang and Vala Afshar. The show airs live at 11:00 a.m. PT/ 2:00 p.m. ET every Friday. Brought to you by Constellation Executive Network: constellationr.com/CEN.

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: EMA, Merck, Chiesi, Uniqure, LabCorp, Chiltern, Covance, Avara International, Pfizer, QuintilesIMS, FDA, Celgene, Agios Pharmaceuticals.Persone: Tommasina Iorno (UNIAMO FIMR).Nuove terapie: AMT-060, Idhifa. Patologie: emofilia B, leucemia mieloide acuta.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: EMA, Merck, Chiesi, Uniqure, LabCorp, Chiltern, Covance, Avara International, Pfizer, QuintilesIMS, FDA, Celgene, Agios Pharmaceuticals.Persone: Tommasina Iorno (UNIAMO FIMR).Nuove terapie: AMT-060, Idhifa. Patologie: emofilia B, leucemia mieloide acuta.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: GSK, ISS, QuintilesIMS, Elsevier, FDA, Gedeon Richter, Recordati, Janssen, AIFA.Persone: Luis Arosemena (GSK), Daniele Finocchiaro (GSK), Rodolfo Lena (Commissione Politiche Sociali e Salute), Sergio Liberatore (QuintilesIMS), Richard Pazdur (FDA).Nuove terapie: nerlynx, cariprazina, guselkumab.Patologie: malattia coronarica, tumore al seno, schizofrenia, psoriasi.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: GSK, ISS, QuintilesIMS, Elsevier, FDA, Gedeon Richter, Recordati, Janssen, AIFA.Persone: Luis Arosemena (GSK), Daniele Finocchiaro (GSK), Rodolfo Lena (Commissione Politiche Sociali e Salute), Sergio Liberatore (QuintilesIMS), Richard Pazdur (FDA).Nuove terapie: nerlynx, cariprazina, guselkumab.Patologie: malattia coronarica, tumore al seno, schizofrenia, psoriasi.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

Ever since my earliest of days in this industry I’ve be fascinated by Corporate Career Sites. It’s also become very clear to me in recent years that career sites should absolutely be the focal point of the new approaches we are seeing in recruitment marketing. Unfortunately I don’t think many employers have realised just how critical their career site is to their recruiting success. One person who does understand this though is my guest this week. Adam Templeman is Head of Commercial Staffing at QuintilesIMS. He has recently helped launched a new careers site for the organization and has some great insights to share. In the interview we discuss:     •    How recruitment marketing challenges have stayed the same but the answers to them have changed     •    The vital importance of engaging with target audiences     •    Using rich, dynamic and targeted content on career sites     •    Getting ATS integration right to increase conversions and improve candidate experience     •    Matching employer brand to employee experience Adam also gives us his views on the importance of automation and talks about what is next for QuintilesIMS Subscribe to this podcast in iTunes

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: QuintilesIMS, Google, Novartis, Boehringer Ingelheim, Gilead, Bristol-Myers Squibb, AIFA.Persone: Sabine Greulich (Boehringer Ingelheim), Valentino Confalone (Gilead), Fouad Namouni (Bristol-Myers Squibb), Emilia De Biasi (Commissione Sanità del Senato), Giuseppe Pelicci (Acc genomics).Patologie: cancro del colon-retto, tumori, carcinoma mammario, malattia di Huntington.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: QuintilesIMS, Google, Novartis, Boehringer Ingelheim, Gilead, Bristol-Myers Squibb, AIFA.Persone: Sabine Greulich (Boehringer Ingelheim), Valentino Confalone (Gilead), Fouad Namouni (Bristol-Myers Squibb), Emilia De Biasi (Commissione Sanità del Senato), Giuseppe Pelicci (Acc genomics).Patologie: cancro del colon-retto, tumori, carcinoma mammario, malattia di Huntington.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

Personalization is the future of healthcare. New technologies such as artificial intelligence, virtual reality, blockchain, and wearable devices -- all connected in the cloud -- are making possible the democratization of diagnosis, medical knowledge, and patient care. This episode explores the near-term future of healthcare, in which with every stakeholder, doctor, pharmacist, payer and patient receives the personalized information they need to make better informed decisions.

Personalization is the future of healthcare. New technologies such as artificial intelligence, virtual reality, blockchain, and wearable devices -- all connected in the cloud -- are making possible the democratization of diagnosis, medical knowledge, and patient care. This episode explores the near-term future of healthcare, in which with every stakeholder, doctor, pharmacist, payer and patient receives the personalized information they need to make better informed decisions.

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: QuintilesIMS, Teva Pharmaceutical Industries, Mylan, Novartis, Sandoz, Pfizer, Allergan, Sun Laboratories, Fresenius, Endo International, Lupin, Sanofi, Aspen Pharmacare, Aurobindo, Cipla, Apotex, Dr. Reddy's, Ypsomed.Persone: Alessandro Mostaccio (Movimento dei consumatori), Federico Spandonaro (Università Tor Vergata di Roma), Andrea Giustina (Università Vita e Salute San Raffaele), Annamaria Vezzani (Istituto Mario Negri di Milano), Pier Paolo di Fiore (IFOM), Sara Sigismund (Università Statale di Milano), Carlo Tacchetti (Ospedale San Raffaele di Milano), Giancarlo Agnelli (Università di Perugia), Andrea Fontanella (FADOI), Massimo Galli (Università degli Studi di Milano), François Houÿez (EURORDIS), Marco Romano (Chiltern International). Nuove terapie: elbasvir/grazoprevir.Patologie: allergie, diabete, epilessia, cancro, tromboembolismo, epatite C.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: QuintilesIMS, Teva Pharmaceutical Industries, Mylan, Novartis, Sandoz, Pfizer, Allergan, Sun Laboratories, Fresenius, Endo International, Lupin, Sanofi, Aspen Pharmacare, Aurobindo, Cipla, Apotex, Dr. Reddy's, Ypsomed.Persone: Alessandro Mostaccio (Movimento dei consumatori), Federico Spandonaro (Università Tor Vergata di Roma), Andrea Giustina (Università Vita e Salute San Raffaele), Annamaria Vezzani (Istituto Mario Negri di Milano), Pier Paolo di Fiore (IFOM), Sara Sigismund (Università Statale di Milano), Carlo Tacchetti (Ospedale San Raffaele di Milano), Giancarlo Agnelli (Università di Perugia), Andrea Fontanella (FADOI), Massimo Galli (Università degli Studi di Milano), François Houÿez (EURORDIS), Marco Romano (Chiltern International). Nuove terapie: elbasvir/grazoprevir.Patologie: allergie, diabete, epilessia, cancro, tromboembolismo, epatite C.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: INC Research, inVentiv Health, GSK, EMA, QuintilesIMS, PRA, Assobiotec, EUSA Pharma.Persone: Micheal Bell (inVentiv Health), Alistar Macdonald (INC Research), Rino Rappuoli (GKS), Guido Rasi (EMA), Beatrice Lorenzin (Ministro della Salute), Manlio Florenzano (Italian Biosimilars Group), Mark Sorrentino (PRA), Riccardo Palmisano (Assobiotec), Bruno Daniele (Ospedale Rummo di Benevento). Nuove terapie: dinutuximab beta, nivolumab.Patologie: neuroblastoma, tumore al fegato.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: INC Research, inVentiv Health, GSK, EMA, QuintilesIMS, PRA, Assobiotec, EUSA Pharma.Persone: Micheal Bell (inVentiv Health), Alistar Macdonald (INC Research), Rino Rappuoli (GKS), Guido Rasi (EMA), Beatrice Lorenzin (Ministro della Salute), Manlio Florenzano (Italian Biosimilars Group), Mark Sorrentino (PRA), Riccardo Palmisano (Assobiotec), Bruno Daniele (Ospedale Rummo di Benevento). Nuove terapie: dinutuximab beta, nivolumab.Patologie: neuroblastoma, tumore al fegato.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: AIFA, EMA, Aristo Pharma, QuintilesIMS, PSI CRO, INC Research, Chiltern, Parexel, ICON, PPD, Amgen, PTC Therapeutics.Persone: Giuseppe Sala (Sindaco di Milano), Giorgio Foresti (Aristo Pharma), Filippo Boschetti (QuintilesIMS), Marcello D’Amelio (Università Campus Bio-Medico di Roma), Glenis Willmott (Parlamento Europeo), Eugenio Mercuri (Università Cattolica di Roma), Manuela Maronati (PTC Therapeutics).Nuove terapie: Blinatumomab, Ataluren.Patologie: depressione, Alzheimer, leucemia linfoblastica acuta, distrofia di Duchenne.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: AIFA, EMA, Aristo Pharma, QuintilesIMS, PSI CRO, INC Research, Chiltern, Parexel, ICON, PPD, Amgen, PTC Therapeutics.Persone: Giuseppe Sala (Sindaco di Milano), Giorgio Foresti (Aristo Pharma), Filippo Boschetti (QuintilesIMS), Marcello D’Amelio (Università Campus Bio-Medico di Roma), Glenis Willmott (Parlamento Europeo), Eugenio Mercuri (Università Cattolica di Roma), Manuela Maronati (PTC Therapeutics).Nuove terapie: Blinatumomab, Ataluren.Patologie: depressione, Alzheimer, leucemia linfoblastica acuta, distrofia di Duchenne.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/